Abstract
We provide clinical commentary on this edition’s case report of immune-mediated encephalitis related to daclizumab therapy.
Get full access to this article
View all access options for this article.
References
1.
Devlin
M
Swayne
A
Newman
M
et al
. A case of immune-mediated encephalitis related to daclizumab therapy . Mult Scler 2019 ; 25 : 750 –753 .
2.European Medicines Agency . Assessment report . Zinbryta . 2016 , www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/003862/WC500210601.pdf
3.European Medicines Agency . Assessment report. Procedure under Article 20 of Regulation (EC) No 726/2004 resulting from pharmacovigilance data . Zinbryta . 2017 , www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/003862/WC500241256.pdf
4.European Medicines Agency . EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders . 2018 , www.ema.europa.eu/docs/en_GB/document_library/Press_release/2018/03/WC500244890.pdf